International, Randomized, Placebo-Controlled Trial Of Cc-486 (Oral Azacitidine) In Patients With Ipss Intermediate-1 Myelodysplastic Syndromes With Rbc-Transfusion-Dependent Anemia And Thrombocytopenia: The Quazar Lower-Risk Mds Trial

AuthID
 P-00P-BTY
13
Author(s)
Garcia Manero, G
·
Platzbecker, U
·
Santini, V
·
Voso, MT
·
Garcia, R
·
Valcarcel, D
·
Silverman, LR
·
Giagounidis, A
·
Larsen, SR
·
Kreitz, S
·
Hoenekopp, A
·
Skikne, BS
Document Type
Abstract
Year published
2015
Published
in LEUKEMIA RESEARCH, ISSN: 0145-2126
Volume: 39, Pages: S51-S52 (2)
Conference
13Th International Symposium on Myelodysplastic Syndromes (Mds), Date: APR 29-MAY 02, 2015, Location: Washington, DC
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000373183500101
Source Identifiers
ISSN: 0145-2126
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service